Claire Aldridge

Venture Partner

Independent director of Alexandria Real Estate Equities (NYSE: ARE) and a scientific advisory board member at Colossal Biosciences. Built her career in technology transfer and venture development, including at UT Southwestern and Remeditex Ventures. Holds a PhD from Duke University.

• Forbes — 10 Women Leading the Synthetic Biology Revolution
• Independent Director, Alexandria Real Estate Equities (NYSE: ARE)
• Scientific Advisory Board, Colossal Biosciences Inc.
• Former Chief Strategy Officer, Form Bio & VP at Remeditex Ventures
• PhD in Immunology and Genetics — Duke University